pedro berraondo
Program of Immunology and Immunotherapy, Cima Universidad de Navarra
Pamplona, Spain
Associate Editor
Cancer Immunity and Immunotherapy
Program of Immunology and Immunotherapy, Cima Universidad de Navarra
Pamplona, Spain
Associate Editor
Cancer Immunity and Immunotherapy
Department of Clinical and Experimental Medicine, University of Messina
Messina, Italy
Associate Editor
Molecular and Cellular Oncology
University of Brescia
Brescia, Italy
Associate Editor
Genitourinary Oncology
University of Texas MD Anderson Cancer Center
Houston, United States
Associate Editor
Cancer Immunity and Immunotherapy
University of Padua
Padua, Italy
Associate Editor
Neuro-Oncology and Neurosurgical Oncology
Dipartimento di Ent, Ospedale Civile di Vittorio Veneto
Vittorio Veneto, Italy
Associate Editor
Head and Neck Cancer
European Institute of Oncology (IEO)
Milan, Italy
Associate Editor
Cancer Genetics
Federation University Australia
Ballarat, Australia
Associate Editor
Cancer Immunity and Immunotherapy
Sackler Faculty of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University
Tel Aviv, Israel
Associate Editor
Cancer Immunity and Immunotherapy
College of Medicine, University of Cincinnati
Cincinnati, United States
Associate Editor
Molecular and Cellular Oncology
Oswaldo Cruz Foudantion (FIOCRUZ)
Salvador, Brazil
Associate Editor
Molecular and Cellular Oncology
Saveetha Medical College & Hospital
Chennai, India
Associate Editor
Pharmacology of Anti-Cancer Drugs
Irell & Manella Graduate School of Biological Sciences, City of Hope
Duarte, United States
Associate Editor
Pediatric Oncology
Institute of Cancer Research (ICR)
London, United Kingdom
Associate Editor
Head and Neck Cancer
University of Texas MD Anderson Cancer Center
Houston, United States
Associate Editor
Gynecological Oncology
National Institute of Technology Rourkela
Rourkela, India
Associate Editor
Cancer Metabolism